With Cipla’s continuous efforts in ensuring treatments to detect and challenge this COVID-19 pandemic, the new COVID-19 RT-PCR test kit ‘ViraGen’ by Cipla has been launched and is now available in the market. The drug major partnered with Ubio Biotechnology Systems for the development of this New ViraGen test kit. As per Cipla’s regulatory filing, this launch of the ViraGen COVID-19 test will aid in addressing the ongoing testing and diagnosis issues in COVID-19 due to capacity while moving forward with the company’s expansion in the diagnostic field.
This New COVID-19 RT-PCR test will be very fruitful to boost up the COVID-19 diagnosis. ViraGen Cipla test kit has concluded the lagging demand of diagnostic kit and hence the management of COVID-19. ViraGen COVID-19 test kit is Cipla’s third effort towards COVID-19 testing.
How does the ViraGen COVID-19 Test work?
ViraGen COVID-19 test is Cipla’s latest offering towards COVID-19 management and care. ViraGen Cipla test kit has received approval from the Indian Council of Medical Research (ICMR) as a diagnostic kit for COVID-19. ViraGen Cipla test kit is a real-time detection kit. It is based upon the multiplex Polymerase Chain Reaction (PCR) technology.
ViraGen assists in the diagnosis and detection of the SARS-CoV-2 N gene and the ORF lab gene. It provides specificity of 98.8% and a sensitivity of 98.6% when compared with the ICMR standard tests. ViraGen Cipla test kit performs qualitative detection. ViraGen COVID-19 test kit detects the nucleic acid from SARS-CoV-2, both in the lower and the upper respiratory specimens from individuals who have symptoms of COVID-19.
ViraGen and COVID-19 in India
With the COVID-19 infection being widespread, there is always a need for diagnostic kits which can detect the virus at the initial stages and help in controlling further expansion. There has been antigen testing and RT-PCR testing being extensively used to track down and break the chain of coronavirus infection. Cipla has already partnered for antigen and antibody detection kits. This New COVID-19 RT-PCR test kit is now easily accessible from the market. The ViraGen COVID test kit is one step forward towards this motive by Cipla. Cipla has also taken various other efforts towards the ongoing COVID-19 pandemic in the past.
Why the ViraGen COVID-19 test?
At present, the real-time PCR test is the uttermost reliable, accurate and preferred method for the detection of COVID-19 in symptoms. ViraGen COVID-19 test being the real-time detection kit provides the highest accuracy and diagnosis if there is the existence of coronavirus in your system. The test involves sampling on a nasal swab or a throat swab that is sent to a laboratory to be analysed for further diagnosis. The RT-PCR test continues to be the “gold standard” for diagnosing COVID-19.
India, being one of the most populated countries, turned into a COVID-19 warplace. The need for diagnosis of COVID-19 before one individual infects another individual is crucial. The New ViraGen test kit was the need of the hour. This New COVID-19 RT-PCR test kit will help manage the volume. A densely populated country like India will benefit from the ViraGen Cipla test kit. Cipla has used its market distributors to make sure that ViraGen is available in the market from May 25, 2021.
In case one shows symptoms of COVID-19 infection like high fever, dry cough, loss of smell or taste, sore throat or breathing issue, it would be smart to choose the New ViraGen test kit to have accurate results. Even if one may have been in contact with any individual who has tested positive, they should undergo COVID-19 testing.
In case you are diagnosed positive of COVID-19, isolate yourself to protect the ones you love and stop the infection chain. Keep a thermometer and oximeter handy and maintain track of your temperature and oxygen levels. Contact your healthcare provider immediately and take the medications as per their suggestion. Also, do not stop taking the precautionary measures of covering your face and mouth and regular sanitisation of hands to control the spread of the virus.
Disclaimer: The information included at this site is for educational purposes only and is not intended to be a substitute for medical treatment by a healthcare professional. Because of unique individual needs, the reader should consult their physician to determine the appropriateness of the information for the reader’s situation.